
Humira
Adalimumab injectable solution for rheumatoid arthritis and psoriatic arthritis. A biologic that blocks TNF-alpha, a molecule that fuels joint inflammation.
- Category
- Autoimmune Support
- Active ingredient
- Adalimumab
- Route
- Subcutaneous use
- Form
- Injectable Solution
- Strengths
- 20mg / 0.4ml · 40mg / 0.8ml
This listing uses Humira as a reference name. A generic equivalent is supplied; its exact brand and manufacturer are confirmed before supply.
Prescription and consultation requirements for Humira vary by destination and are determined by the fulfilment partner.
Humira details
- Conditions
- Rheumatoid Arthritis · Psoriatic Arthritis · Ankylosing Spondylitis · Crohn's Disease · Ulcerative Colitis · Plaque Psoriasis
- Alternative names
- adalimumab
- Therapeutic class
- Tumour Necrosis Factor (TNF) Blocker
- Pharmacological class
- Monoclonal Antibody
- Contraindications
- severe active infection; moderate to severe congestive heart failure
- Minor side effects
- injection site pain; headache; rash
- Moderate side effects
- upper respiratory tract infection; sinusitis; nausea
- Dosage forms
- Injectable Solution
- Administration route
- Subcutaneous use
- Supply category
- Prescription-only medicine (POM)
- Originator
- AbbVie
- Onset Time
- 2–4 weeks
- Duration
- 10–14 days
- Storage instructions
- Store between 2°C and 8°C. Do not freeze.
- Drug interactions
- Abatacept; Anakinra; Live Vaccines
- Age restrictions
- Approved for children over two years and adults based on indication.
Serious side effects
severe systemic sepsis, requires immediate medical attention; malignancy development, requires immediate medical attention; demyelinating disease activation, requires immediate medical attention
Patient summary
Adalimumab injectable solution for rheumatoid arthritis and psoriatic arthritis. A biologic that blocks TNF-alpha, a molecule that fuels joint inflammation.
Mechanism of action
Binds specifically to TNF-alpha, neutralising its interaction with cell surface receptors to halt the inflammatory cascade.
Pregnancy and breastfeeding
Pregnancy: Consult clinician. Breastfeeding: Confirm breastfeeding suitability with a qualified clinician or pharmacist before use.
What you will receive
Humira is used here as a reference originator brand name to identify the medicine. We are not affiliated with the brand owner, and this listing does not offer the originator product.
- The supplied product is a generic equivalent containing Adalimumab, not the originator brand shown as the reference.
- The exact generic brand, manufacturer and dispatch location are confirmed based on the product, destination and available manufacturer or partner warehouse.
- Check the final product details at checkout before confirming an order.